Compare BABA & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BABA | MRK |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | Hong Kong | United States |
| Employees | 128197 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.4B | 268.7B |
| IPO Year | N/A | 1994 |
| Metric | BABA | MRK |
|---|---|---|
| Price | $129.60 | $122.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $185.15 | $125.59 |
| AVG Volume (30 Days) | ★ 9.3M | 6.9M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | 0.81% | ★ 3.06% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | $5.05 | $3.61 |
| Revenue Next Year | $10.83 | $5.41 |
| P/E Ratio | $21.20 | ★ N/A |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $107.19 | $75.40 |
| 52 Week High | $192.67 | $125.14 |
| Indicator | BABA | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 67.63 |
| Support Level | $129.29 | $112.49 |
| Resistance Level | $140.72 | $124.57 |
| Average True Range (ATR) | 4.43 | 2.30 |
| MACD | -0.92 | 1.02 |
| Stochastic Oscillator | 14.24 | 97.31 |
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China retail e-commerce platform is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China wholesale e-commerce, international retail and wholesale e-commerce, local consumer services, travel services, cloud computing, digital media and entertainment, Cainiao logistics services, and other businesses.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).